Email us for help
Loading...
Premium support
Log Out
Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.
A conversation with Brian M. Overstreet, founder and president of Adverse Events, Inc., about the challenges FDA faces in reporting adverse drug events to the public and the impact on patient safety.